2013 FDLI International Conference

China-US Updates in Food and Drug Law 

October 15 - 16 | Beijing, China  

Join the Food and Drug Law Institute (FDLI) for a two-day conference where government officials and internationally renowned experts will discuss pharmaceutical, medical device and food law, regulation and policy in China and the United States. The conference will focus on updates in regulations, business opportunities and policy challenges to producing safe products and promoting the public health.

If you attended FDLI’s first China-US Conference in 2011, you know that this unique program provided an opportunity to learn about regulatory developments and to network for future cooperative ventures. The 2013 conference will offer even more practical discussion about the enormous amount of changes in food and drug law in both countries, including the impact of the historic Food Safety and Modernization Act (FSMA) and major changes on the horizon for China's Food and Drug Administration. 

China is an established world player in the pharmaceutical, medical device and food space. From smaller startups to multinationals, companies are staking a foothold in the region. Understanding the China Food and Drug Administration (CFDA) and other Chinese regulatory bodies, including the importance of the potential creation of a superagency to monitor food safety, is essential to understanding the Chinese market. At this meeting, you’ll hear first-hand about: 

  • The creation of a new agency that could dramatically affect the manufacturing and importation of food in China.
  • Why the medical device industry in China is viewed as an incredible growth area for both Chinese and multi-national companies.
  • The necessity of having a local partner if you want to manufacture pharmaceuticals in China.
  • Why importation of food, drug and medical devices into the United States is more complex than ever.  
  • Success stories of doing business in China — directly from the manufacturers.

We’ve taken the best from our first conference in China, US-China Food and Drug Law - Ensuring Quality, Improving Safety, Expanding Access, and made it even more useful and worthwhile for attendees in 2013.

Who Should Attend

  • Regulatory and Government Affairs, Business Development, Global Strategy, Corporate Planning, and Safety and Compliance staff of multi-national food, pharmaceutical, dietary supplement and medical device companies doing business or planning to do business in China.
  • Representatives of Chinese food, pharmaceutical and medical device companies or those who wish to partner with these companies 
  • Food, Drug and Device Attorneys
  • Government Officials
  • Academics
  • Food, Drug and Device Industry Consultants

2011 Attendees Included:

3M Health Care
Akin Gump Strauss Hauer & Feld LLP
Amway Corporation
Arnold & Porter LLP
Bausch & Lomb, Incorporated
Bayer Corporation
Becker & Associates Consulting, Inc.
Boston Scientific Corporation Inc.
Brewster Law Firm LLC
Bric Global Agricultural Consultant Ltd.
Cargill, Inc.
CaridianBCT Inc.
China Association of Fragrance Flavor and Cosmetic Industries
China Nonprescription Medicines Association 
Chubb Commercial Insurance 
Coca-Cola Enterprises Inc. 
Colgate-Palmolive Company
Cook Group Incorporated
Coty Inc.
Covington & Burling LLP
Cybernet System Management, Inc.
Duane Morris LLP
Dun & Bradstreet, Inc.
Eastman Chemical Company
Ecolab Inc.
ELC Innovation Institute
Embassy of the United States - China
Energizer Battery Company
Eurofins Scientific
Fangda Partners
FDAImports.com, LLC
Food Standards Australia New Zealand
Frank Rocco & Associates
Fulbright & Jaworski L.L.P.
GE Healthcare
GIC Group
HACCP Asia Pacific
Hangzhou MSD Pharmaceutical Co., Ltd.
Health Law Research Center
Herbalife International of America Inc
Johnson & Johnson
Jun He Law Offices
Kaplan EduNeering
Keller and Heckman LLP
Kelley Drye & Warren LLP
King & Spalding LLP
King & Wood
Leavitt Partners Global Food Safety Solutions Mars, Inc.
Mary Kay Cosmetics Inc
Medtronic Medical Appliance Technology & Service (Shanghai) 
Medtronic Vascular 
Medtronic, Inc.
Melaleuca, Incorporated
Microsoft Health Solutions Group
Ministry of Health Malaysia
National Consumers League
Natural Products Association
NBTY, Inc.
Norton Rose LLP

Novartis Country Organization, China
Novartis Nutrition Corporation
Novartis Pharma AG
Ohio State University
Orrick, Herrington & Sutcliffe LLP
Peking University
Personal Care Products Council
Pfizer, Inc.
PharmAsia News
Philips Medical Systems, N.A.
Procter & Gamble Pharmaceuticals
Procuro, Inc.
Queensland University of Technology
Quintiles Consulting
Radiometer Medical A/S
Reed Smith LLP
Ropes & Gray LLP
Saladax Biomedical, Inc.
Sandoz China
Schick Wilkinson-Sword
Shaklee Corporation
Sidley Austin LLP
Silliker, Inc.
Singapore Stanford Biodesign
Sino Analytica
Skadden, Arps, Slate, Meagher & Flom LLP 
State Food and Drug Administration, P.R. China 
Suzhou Novartis Pharma Technology 
Takeda Pharmaceuticals North America, Inc.
Terumo Cardiovascular Systems
Terumo China
Tibet Chamber of Commerce
TSI Group Company
Tsinghua University Law School
Tyson Foods, Inc.
U.S. China Business Council
U.S. China Health Products Association
U.S. Department of Commerce
U.S. Embassy Beijing
U.S. Pharmacopeia
UCLA School of Law
Unilever Research
University of Houston
University of Phoenix
Upstream Consulting, Inc.
Validation Plus, Inc.
Varian Medical Systems
Venable LLP
W.L. Gore & Associates, Inc.
Wilson Nutritech Co., Ltd.
Wockhardt Limited
Xian-Janssen Pharmaceutical Ltd.
YUM! Restaurants, China Division

Please use the tool below to change the text of this website into a different language.